VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 137 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $781,000 | +12.9% | 41,000 | 0.0% | 0.56% | +77.6% |
| Q1 2018 | $692,000 | -38.6% | 41,000 | -44.6% | 0.31% | -36.3% |
| Q4 2017 | $1,127,000 | -14.8% | 74,000 | 0.0% | 0.49% | +2.9% |
| Q3 2017 | $1,323,000 | +9.9% | 74,000 | 0.0% | 0.48% | +3.0% |
| Q2 2017 | $1,204,000 | +16.4% | 74,000 | 0.0% | 0.46% | +18.4% |
| Q1 2017 | $1,034,000 | +24.4% | 74,000 | +42.3% | 0.39% | -16.3% |
| Q4 2016 | $831,000 | -3.9% | 52,000 | 0.0% | 0.47% | -10.2% |
| Q3 2016 | $865,000 | +48.6% | 52,000 | 0.0% | 0.52% | +10.9% |
| Q2 2016 | $582,000 | +34.1% | 52,000 | 0.0% | 0.47% | +225.7% |
| Q1 2016 | $434,000 | +19.6% | 52,000 | +33.3% | 0.14% | -26.5% |
| Q4 2015 | $363,000 | -70.4% | 39,000 | -64.2% | 0.20% | -66.0% |
| Q3 2015 | $1,228,000 | +148.1% | 109,000 | +179.5% | 0.58% | +260.0% |
| Q2 2015 | $495,000 | – | 39,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |